Apimeds Pharmaceuticals US, Inc. (APUS) stock
APUSNYSEPharmaceutical PreparationsFiscal year ends December 31
$1.95−0.09 (-4.41%)
Close on Nov 17, 2026Market cap $2.94MP/E –Yield –
Apimeds Pharmaceuticals US price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Apimeds Pharmaceuticals US's price to book ratio was 0.0× on Nov 11, 2026, against 4.5× a year earlier.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.0× | −2.5 |
| 2025 | Dec 31, 2025 | 2.5× | – |
See a number that looks wrong?